NCT04766060

Brief Summary

A serious complication to colorectal surgery is anastomotic leakage (AL). AL increases post-operative mortality, decreases long-term survival, reduces the functional result and reduces qual-ity of life. Studies suggest that performing an indocyanine-green enhanced fluorescent angi-ography (ICGeFA), blood perfusion in the bowel can be visualised. It is suggested that using this procedure the relative risk of AL is reduced about 54-67%. With this project we wish to evaluate the feasibility of the procedure, and, if proven feasible, to plan further studies evaluating the procedure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2017

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2018

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

February 18, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 23, 2021

Completed
Last Updated

February 23, 2021

Status Verified

February 1, 2021

Enrollment Period

1.7 years

First QC Date

February 18, 2021

Last Update Submit

February 18, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of patients with anastomotic leakage and evaluation of fluorescent imaging in these patients

    Primary surgeons peroperative evaluation of fluoresence

    30 days

Interventions

Fluorescense imaging used to evaluate blood perfusion

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients, older than 18, undergoing robotic surgery for rectal cancer and cancers located low in the sigmoid bowel, \<25 cm form the anal verge.

You may qualify if:

  • robotic surgery for rectal cancer and cancers located low in the sigmoid bowel

You may not qualify if:

  • Allergy of iodide
  • Pregnancy
  • Lactation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Odense University Hospital

Odense, Fyn, 5000, Denmark

Location

Related Publications (1)

  • Larsen PO, Nerup N, Andersen J, Dohrn N, Klein MF, Brisling S, Salomon S, Andersen PV, Moller S, Svendsen MBS, Rahr HB, Iversen LH, Gogenur I, Qvist N, Ellebaek MB. Anastomotic perfusion assessment with indocyanine green in robot-assisted low-anterior resection, a multicenter study of interobserver variation. Surg Endosc. 2023 May;37(5):3602-3609. doi: 10.1007/s00464-022-09819-1. Epub 2023 Jan 9.

MeSH Terms

Conditions

Colorectal NeoplasmsAnastomotic Leak

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

February 18, 2021

First Posted

February 23, 2021

Study Start

April 1, 2017

Primary Completion

November 30, 2018

Study Completion

November 30, 2018

Last Updated

February 23, 2021

Record last verified: 2021-02

Locations